← FDA DRUG APPROVALS

FDA ANDA · ANDA077351

ACID RELIEF

famotidine

Sponsor: PERRIGO R AND D

APPLICATION
ANDA077351
TYPE
ANDA
ORIGINAL APPROVAL
2006-09-25
LATEST ACTION
2021-08-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter

Products

FAMOTIDINEOver-the-counter
FAMOTIDINE 20MG · TABLET · ORAL

Approval history

2021-08-18Manufacturing (CMC) · Supplement 28 · standardAP
2021-02-18Labeling · Supplement 23 · standardAP
2016-04-26Manufacturing (CMC) · Supplement 18 · unknownAP
2006-09-25OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →